Isolation and characterization of faecalibacterium prausnitzii from calves and piglets

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Foditsch, Carla ^a   Santos, Thiago M A ^b   Teixeira, Andre G V ^a   Pereira, Richard V V ^a   Dias, Juliana M ^a   Gaeta, Natália ^a   Bicalho, Rodrigo C ^a  

^a Department of Population Medicine and Diagnostic Sciences College of Veterinary Medicine Cornell University ^*  (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; BILE SALT; BUTYRIC ACID; CEFEPIME; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ENROFLOXACIN; GENTAMICIN; ISOBUTYRIC ACID; NALIDIXIC ACID; NEOMYCIN; PROBIOTIC AGENT; PROPIONIC ACID; SHORT CHAIN FATTY ACID; STREPTOMYCIN; TETRACYCLINE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CALF (BOVINE); CONCENTRATION (PARAMETERS); CULTURE MEDIUM; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; GAS CHROMATOGRAPHY; GENE CLUSTER; IN VIVO STUDY; LIVESTOCK; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PH MEASUREMENT; PIGLET; ANIMAL; BOVINE; CLOSTRIDIALES; FECES; GENETIC VARIATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTESTINE FLORA; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYLOGENY; PIG;

ANIMALIA; BACTERIA (MICROORGANISMS); FAECALIBACTERIUM; FAECALIBACTERIUM PRAUSNITZII;

ANIMALS; CATTLE; CLOSTRIDIALES; FECES; GASTROINTESTINAL MICROBIOME; GENETIC VARIATION; PHYLOGENY; PROBIOTICS; SWINE;

EID: 84920419173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116465     Document Type: Article

References (42)

1. Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9: 313-323.
2. Peterson DA, Cardona RA (2010) Specificity of the adaptive immune response to the gut microbiota. Adv Immunol 107: 71-107.
3. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214.
4. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
5. Balamurugan R, George G, Kabeerdoss J, Hepsiba J, Chandragunasekaran AM, et al. (2010) Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br J Nutr 103: 335-338.
6. Wang W, Chen L, Zhou R, Wang X, Song L, et al. (2013) Increased proportion of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol.
7. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, et al. (2013) A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut.
8. Qiu X, Zhang M, Yang X, Hong N, Yu C (2013) Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J Crohns Colitis 7: e558-68.
9. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736.
10. Duncan SH, Hold GL, Harmsen HJ, Stewart CS, Flint HJ (2002) Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol 52: 2141-2146.
11. Hold GL, Schwiertz A, Aminov RI, Blaut M, Flint HJ (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69: 4320-4324.
12. Suau A, Rochet V, Sghir A, Gramet G, Brewaeys S, et al. (2001) Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol 24: 139-145.
13. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, et al. (2011) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5: 220-230.
14. Oikonomou G, Teixeira AG, Foditsch C, Bicalho ML, Machado VS, et al. (2013) Fecal microbial diversity in pre-weaned dairy calves as described by pyrosequencing of metagenomic 16S rDNA. associations of Faecalibacterium species with health and growth. PLoS One 8: e63157.
15. Haenen D, Zhang J, Souza da Silva C, Bosch G, van der Meer IM, et al. (2013) A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr 143: 274-283.
16. Nava GM, Stappenbeck TS (2011) Diversity of the autochthonous colonic microbiota. Gut Microbes 2: 99-104.
17. Lund M, Bjerrum L, Pedersen K (2010) Quantification of Faecalibacterium prausnitzii- and subdoligranulum variabile-like bacteria in the cecum of chickens by real-time PCR. Poult Sci 89: 1217-1224.
18. Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, et al. (2000) Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66: 1654-1661.
19. Maynard LA (1979) Animal nutrition. New York: McGraw-Hill. 474 p.
20. Ploger S, Stumpff F, Penner GB, Schulzke JD, Gabel G, et al. (2012) Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci 1258: 52-59.
21. Guan LL, Nkrumah JD, Basarab JA, Moore SS (2008) Linkage of microbial ecology to phenotype: Correlation of rumen microbial ecology to cattle's feed efficiency. FEMS Microbiol Lett 288: 85-91.
22. Gorka P, Kowalski ZM, Pietrzak P, Kotunia A, Jagusiak W, et al. (2011) Effect of method of delivery of sodium butyrate on rumen development in newborn calves. J Dairy Sci 94: 5578-5588.
23. Wood J, Scott KP, Avgustin G, Newbold CJ, Flint HJ (1998) Estimation of the relative abundance of different Bacteroides and Prevotella ribotypes in gut samples by restriction enzyme profiling of PCRamplified 16S rRNA gene sequences. Appl Environ Microbiol 64: 3683-3689.
24. Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJ, Garcia-Gil LJ, et al. (2012) Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol 78: 420-428.
25. Wang G, Whittam TS, Berg CM, Berg DE (1993) RAPD (arbitrary primer) PCR is more sensitive than multilocus enzyme electrophoresis for distinguishing related bacterial strains. Nucleic Acids Res 21: 5930-5933.
26. Supelco I (1998) Analyzing fatty acids by packed column gas chromatography. Bulletin 856B 2014.
27. Rosenblatt JE, Gustafson DR (1995) Evaluation of the Etest for susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis 22: 279-284.
28. Chin NX, Neu HC (1984) Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 25: 319-326.
29. Wust J, Wilkins TD (1978) Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing. Antimicrob Agents Chemother 14: 384-390.
30. Khan MT, Duncan SH, Stams AJ, van Dijl JM, Flint HJ, et al. (2012) The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases. ISME J 6: 1578-1585.
31. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, et al. (2004) Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 91: 915-923.
32. Wrzosek L, Miquel S, Noordine ML, Bouet S, Joncquel Chevalier-Curt M, et al. (2013) Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol 11: 61-7007-11-61.
33. Dressman JB, Berardi RR, Dermentzoglou LC, Russell TL, Schmaltz SP, et al. (1990) Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 7: 756-761.
34. Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, et al. (2013) Connecting dysbiosis, bileacid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62: 531-539.
35. van den Bogaard AE, Willems R, London N, Top J, Stobberingh EE (2002) Antibiotic resistance of faecal enterococci in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother 49: 497-505.
36. Bryan LE, Kowand SK, Van Den Elzen HM (1979) Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob Agents Chemother 15: 7-13.
37. Magnet S, Blanchard JS (2005) Molecular insights into aminoglycoside action and resistance. Chem Rev 105: 477-498.
38. Scott KP, Melville CM, Barbosa TM, Flint HJ (2000) Occurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut. Antimicrob Agents Chemother 44: 775-777.
39. Seville LA, Patterson AJ, Scott KP, Mullany P, Quail MA, et al. (2009) Distribution of tetracycline and erythromycin resistance genes among human oral and fecal metagenomic DNA. Microb Drug Resist 15: 159-166.
40. Kazimierczak KA, Scott KP, Kelly D, Aminov RI (2009) Tetracycline resistome of the organic pig gut. Appl Environ Microbiol 75: 1717-1722.
41. Barbosa TM, Scott KP, Flint HJ (1999) Evidence for recent intergeneric transfer of a new tetracycline resistance gene, tet(W), isolated from Butyrivibrio fibrisolvens, and the occurrence of tet(O) in ruminal bacteria. Environ Microbiol 1: 53-64.
42. Chee-Sanford JC, Aminov RI, Krapac IJ, Garrigues-Jeanjean N, Mackie RI (2001) Occurrence and diversity of tetracycline resistance genes in lagoons and groundwater underlying two swine production facilities. Appl Environ Microbiol 67: 1494-1502.